- Home
- INBX vs DIN Comparison
INBX vs DIN Comparison
Compare INBX & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- DIN
- Stock Information
- Founded
- INBX 2010
- DIN 1958
- Country
- INBX United States
- DIN United States
- Employees
- INBX N/A
- DIN N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- DIN Restaurants
- Sector
- INBX Health Care
- DIN Consumer Discretionary
- Exchange
- INBX Nasdaq
- DIN Nasdaq
- Market Cap
- INBX 430.2M
- DIN 353.9M
- IPO Year
- INBX 2020
- DIN 1991
- Fundamental
- Price
- INBX $33.88
- DIN $26.90
- Analyst Decision
- INBX Hold
- DIN Hold
- Analyst Count
- INBX 2
- DIN 9
- Target Price
- INBX N/A
- DIN $26.57
- AVG Volume (30 Days)
- INBX 123.8K
- DIN 583.5K
- Earning Date
- INBX 11-13-2025
- DIN 11-05-2025
- Dividend Yield
- INBX N/A
- DIN 7.32%
- EPS Growth
- INBX N/A
- DIN N/A
- EPS
- INBX N/A
- DIN 2.99
- Revenue
- INBX $1,400,000.00
- DIN $845,368,000.00
- Revenue This Year
- INBX $563.00
- DIN $11.28
- Revenue Next Year
- INBX $230.77
- DIN $2.11
- P/E Ratio
- INBX N/A
- DIN $9.33
- Revenue Growth
- INBX N/A
- DIN 2.92
- 52 Week Low
- INBX $10.81
- DIN $18.63
- 52 Week High
- INBX $37.53
- DIN $37.44
- Technical
- Relative Strength Index (RSI)
- INBX 70.20
- DIN 65.54
- Support Level
- INBX $31.75
- DIN $22.85
- Resistance Level
- INBX $37.53
- DIN $28.41
- Average True Range (ATR)
- INBX 1.99
- DIN 1.06
- MACD
- INBX 0.27
- DIN 0.33
- Stochastic Oscillator
- INBX 67.38
- DIN 78.78
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.